|
|
books
| book details |
Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks
Edited by Quanjun Wang, Edited by Qingli Wang, Edited by Xingchao Geng
|
|
| on special |
normal price: R 11 470.95
Price: R 10 323.95
|
| book description |
Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks systematically explores the nonclinical evaluation of Cell and Gene Therapies (CGT) products, emphasizing risk mitigation and innovation. The book provides comprehensive coverage, including 20+ chapters spanning preclinical toxicology, pharmacokinetics, and novel evaluation models. It is the first book to integrate organ-on-chip models into CGT evaluation, reflecting FDA/NMPA modernization initiatives. It includes practical guidance on addressing CRISPR off-target effects, immunogenicity, and long-term carcinogenicity risks.
| product details |
Normally shipped |
Publisher | Elsevier - Health Sciences Division
Published date | 1 Oct 2026
Language |
Format | Paperback / softback
Pages | 1050
Dimensions | 229 x 152 x 0mm (L x W x H)
Weight | 450g
ISBN | 978-0-4434-8612-8
Readership Age |
BISAC | medical / pharmacology
| other options |
|
|
To view the items in your trolley please sign in.
| sign in |
|
|
|
| specials |
|
|
Matt Dinniman
Paperback / softback
480 pages
was: R 522.95
now: R 459.95
|
|
|
An epic love story with the pulse of a thriller that asks: what would you risk for a second chance at first love?
|
|
|
|
|
